129 related articles for article (PubMed ID: 2541903)
21. Effects of yohimbine on autonomic measures are determined by individual values for area under the concentration-time curve.
Grasing K; Sturgill MG; Rosen RC; Trout JR; Thomas TJ; Kulkarni GD; Maines P; Seibold JR
J Clin Pharmacol; 1996 Sep; 36(9):814-22. PubMed ID: 8889902
[TBL] [Abstract][Full Text] [Related]
22. A test of the "epinephrine hypothesis" in humans.
Goldstein DS; Golczynska A; Stuhlmuller J; Holmes C; Rea RF; Grossman E; Lenders J
Hypertension; 1999 Jan; 33(1):36-43. PubMed ID: 9931079
[TBL] [Abstract][Full Text] [Related]
23. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
[TBL] [Abstract][Full Text] [Related]
24. Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in man.
Al-Damluji S; Perry L; Tomlin S; Bouloux P; Grossman A; Rees LH; Besser GM
Neuroendocrinology; 1987 Jan; 45(1):68-76. PubMed ID: 3027604
[TBL] [Abstract][Full Text] [Related]
25. Influence of yohimbine on release of anterior pituitary hormones.
Goldberg MR; Jackson RV; Krakau J; Island DP; Robertson D
Life Sci; 1986 Aug; 39(5):395-8. PubMed ID: 3016439
[TBL] [Abstract][Full Text] [Related]
26. Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.
Krystal JH; Webb E; Cooney N; Kranzler HR; Charney DS
Arch Gen Psychiatry; 1994 Nov; 51(11):898-911. PubMed ID: 7944878
[TBL] [Abstract][Full Text] [Related]
27. Effects of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desimipramine-induced pituitary hormone stimulation in humans--III. Hypothalamo-pituitary-adrenocortical axis.
Laakmann G; Wittmann M; Schoen HW; Zygan K; Weiss A; Meissner R; Mueller OA; Stalla GK
Psychoneuroendocrinology; 1986; 11(4):475-89. PubMed ID: 3031718
[TBL] [Abstract][Full Text] [Related]
28. Yohimbine elimination in normal volunteers is characterized by both one- and two-compartment behavior.
Sturgill MG; Grasing KW; Rosen RC; Thomas TJ; Kulkarni GD; Trout JR; Maines M; Seibold JR
J Cardiovasc Pharmacol; 1997 Jun; 29(6):697-703. PubMed ID: 9234649
[TBL] [Abstract][Full Text] [Related]
29. Epinephrine or norepinephrine fail to influence pituitary-adrenal secretion in man.
Oberbeck R; Schürmeyer T; Hosch W; Jetschmann JU; Schmidt RE; Schedlowski M
Horm Metab Res; 1996 Mar; 28(3):142-6. PubMed ID: 8926014
[TBL] [Abstract][Full Text] [Related]
30. The dissociation of catecholamine and hypothalamic-pituitary-adrenal responses to daily stressors using dexamethasone.
Malarkey WB; Lipkus IM; Cacioppo JT
J Clin Endocrinol Metab; 1995 Aug; 80(8):2458-63. PubMed ID: 7629242
[TBL] [Abstract][Full Text] [Related]
31. Norepinephrine and impulsivity: effects of acute yohimbine.
Swann AC; Lijffijt M; Lane SD; Cox B; Steinberg JL; Moeller FG
Psychopharmacology (Berl); 2013 Sep; 229(1):83-94. PubMed ID: 23559222
[TBL] [Abstract][Full Text] [Related]
32. Differential blocking effects of prazosin and yohimbine on vasopressor responses to sympathetic nerve stimulation and intravenous norepinephrine in the pithed rat.
Lee JY; Walsh GM; Heilman RD; Radzialowski FM
Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):97-112. PubMed ID: 6322258
[TBL] [Abstract][Full Text] [Related]
33. Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers.
Grossman E; Rea RF; Hoffman A; Goldstein DS
Am J Physiol; 1991 Jan; 260(1 Pt 2):R142-7. PubMed ID: 1847020
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers.
Galitzky J; Rivière D; Tran MA; Montastruc JL; Berlan M
Eur J Clin Pharmacol; 1990; 39(5):447-51. PubMed ID: 1963844
[TBL] [Abstract][Full Text] [Related]
35. Effect of the alpha 2-adrenergic antagonist yohimbine on orthostatic tolerance.
Farrow S; Mers A; Banta G; Steigerwalt S; Lockette W
Hypertension; 1990 Jun; 15(6 Pt 2):877-80. PubMed ID: 1972139
[TBL] [Abstract][Full Text] [Related]
36. B-type natriuretic peptide increases cortisol and catecholamine concentrations in healthy subjects.
Grimm G; Resl M; Heinisch BB; Hülsmann M; Luger A; Clodi M; Vila G
J Appl Physiol (1985); 2017 May; 122(5):1249-1254. PubMed ID: 28008098
[TBL] [Abstract][Full Text] [Related]
37. Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls.
Gurguis GN; Vitton BJ; Uhde TW
Psychiatry Res; 1997 Jun; 71(1):27-39. PubMed ID: 9247979
[TBL] [Abstract][Full Text] [Related]
38. A clinical approach for the identification of peripheral pre- and post-synaptic alpha-adrenergic receptors.
Schütz W; Magometschnigg D
J Hypertens; 1986 Aug; 4(4):481-4. PubMed ID: 3021845
[TBL] [Abstract][Full Text] [Related]
39. Evidence for a physiological role of presynaptic alpha-adrenoceptors: modulation of noradrenaline release in the pithed rabbit.
Majewski H; Hedler L; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):256-63. PubMed ID: 6141531
[TBL] [Abstract][Full Text] [Related]
40. Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women.
Berlan M; Galitzky J; Riviere D; Foureau M; Tran MA; Flores R; Louvet JP; Houin G; Lafontan M
Int J Obes; 1991 May; 15(5):305-15. PubMed ID: 1885256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
